• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于CT的放射组学在预测肝细胞癌病理分级中的应用

CT-based radiomics for predicting pathological grade in hepatocellular carcinoma.

作者信息

Huang Yue, Chen Lingfeng, Ding Qingzhu, Zhang Han, Zhong Yun, Zhang Xiang, Weng Shangeng

机构信息

Department of Hepatobiliary Pancreatic Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Fujian Abdominal Surgery Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

出版信息

Front Oncol. 2024 Apr 16;14:1295575. doi: 10.3389/fonc.2024.1295575. eCollection 2024.

DOI:10.3389/fonc.2024.1295575
PMID:38690170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11059035/
Abstract

OBJECTIVE

To construct and validate radiomics models for hepatocellular carcinoma (HCC) grade predictions based on contrast-enhanced CT (CECT).

METHODS

Patients with pathologically confirmed HCC after surgery and underwent CECT at our institution between January 2016 and December 2020 were enrolled and randomly divided into training and validation datasets. With tumor segmentation and feature extraction, radiomic models were constructed using univariate analysis, followed by least absolute shrinkage and selection operator (LASSO) regression. In addition, combined models with clinical factors and radiomics scores (Radscore) were constructed using logistic regression. Finally, all models were evaluated using the receiver operating characteristic (ROC) curve with the area under the curve (AUC), calibration curve, and decision curve analysis (DCA).

RESULTS

In total 242 patients were enrolled in this study, of whom 170 and 72 formed the training and validation datasets, respectively. The arterial phase and portal venous phase (AP+VP) radiomics model were evaluated as the best for predicting HCC pathological grade among all the models built in our study (AUC = 0.981 in the training dataset; AUC = 0.842 in the validation dataset) and was used to build a nomogram. Furthermore, the calibration curve and DCA indicated that the AP+VP radiomics model had a satisfactory prediction efficiency.

CONCLUSIONS

Low- and high-grade HCC can be distinguished with good diagnostic performance using a CECT-based radiomics model.

摘要

目的

构建并验证基于对比增强CT(CECT)的肝细胞癌(HCC)分级预测的放射组学模型。

方法

纳入2016年1月至2020年12月期间在本机构接受手术且病理确诊为HCC并接受CECT检查的患者,并将其随机分为训练集和验证集。通过肿瘤分割和特征提取,采用单变量分析构建放射组学模型,随后进行最小绝对收缩和选择算子(LASSO)回归。此外,使用逻辑回归构建包含临床因素和放射组学评分(Radscore)的联合模型。最后,使用受试者工作特征(ROC)曲线、曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)对所有模型进行评估。

结果

本研究共纳入242例患者,其中170例和72例分别构成训练集和验证集。在我们构建的所有模型中,动脉期和门静脉期(AP + VP)放射组学模型被评估为预测HCC病理分级的最佳模型(训练集中AUC = 0.981;验证集中AUC = 0.842),并用于构建列线图。此外,校准曲线和DCA表明AP + VP放射组学模型具有令人满意的预测效率。

结论

使用基于CECT的放射组学模型可以很好地区分低级别和高级别HCC,诊断性能良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/a7fcf7b801d8/fonc-14-1295575-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/c0227ec14bdd/fonc-14-1295575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/2117fafec4ef/fonc-14-1295575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/2eb86cc7d4ab/fonc-14-1295575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/849bc4ff58b7/fonc-14-1295575-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/6e3849df9def/fonc-14-1295575-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/908f1f50be32/fonc-14-1295575-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/a7fcf7b801d8/fonc-14-1295575-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/c0227ec14bdd/fonc-14-1295575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/2117fafec4ef/fonc-14-1295575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/2eb86cc7d4ab/fonc-14-1295575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/849bc4ff58b7/fonc-14-1295575-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/6e3849df9def/fonc-14-1295575-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/908f1f50be32/fonc-14-1295575-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d18/11059035/a7fcf7b801d8/fonc-14-1295575-g007.jpg

相似文献

1
CT-based radiomics for predicting pathological grade in hepatocellular carcinoma.基于CT的放射组学在预测肝细胞癌病理分级中的应用
Front Oncol. 2024 Apr 16;14:1295575. doi: 10.3389/fonc.2024.1295575. eCollection 2024.
2
Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.基于肝胆期成像预测磷脂酰肌醇蛋白聚糖-3阳性肝细胞癌的影像组学列线图
Front Oncol. 2023 Sep 29;13:1209814. doi: 10.3389/fonc.2023.1209814. eCollection 2023.
3
Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung.基于治疗前双能CT的影像组学列线图用于鉴别肺腺癌与肺鳞癌的开发与验证
Front Oncol. 2022 Nov 23;12:949111. doi: 10.3389/fonc.2022.949111. eCollection 2022.
4
Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.基于术前增强 CT 的影像组学模型预测肝细胞癌患者总生存期。
World J Gastroenterol. 2022 Aug 21;28(31):4376-4389. doi: 10.3748/wjg.v28.i31.4376.
5
Multi-Phase CT-Based Radiomics Nomogram for Discrimination Between Pancreatic Serous Cystic Neoplasm From Mucinous Cystic Neoplasm.基于多期CT的影像组学列线图在鉴别胰腺浆液性囊性肿瘤与黏液性囊性肿瘤中的应用
Front Oncol. 2021 Dec 1;11:699812. doi: 10.3389/fonc.2021.699812. eCollection 2021.
6
Radiomic Analysis of Contrast-Enhanced CT Predicts Glypican 3-Positive Hepatocellular Carcinoma.增强CT的影像组学分析可预测磷脂酰肌醇蛋白聚糖3阳性肝细胞癌
Curr Med Imaging. 2024 Mar 7. doi: 10.2174/0115734056277475240215115629.
7
Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.钆塞酸二钠增强 MRI 的放射组学分析预测肝细胞癌的 Ki-67 表达。
BMC Med Imaging. 2021 Jun 15;21(1):100. doi: 10.1186/s12880-021-00633-0.
8
Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.基于增强 CT 影像组学构建预测晚期 HCC 患者抗 PD-1 抗体治疗疗效的列线图模型的建立与验证
Front Immunol. 2021 Jan 8;11:613946. doi: 10.3389/fimmu.2020.613946. eCollection 2020.
9
Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.基于治疗前 MRI 影像组学和白蛋白-胆红素评分预测不可切除肝细胞癌肝动脉灌注化疗的疗效。
J Cancer Res Clin Oncol. 2023 Jul;149(8):5181-5192. doi: 10.1007/s00432-022-04467-3. Epub 2022 Nov 12.
10
A radiomics nomogram based on contrast-enhanced CT for preoperative prediction of Lymphovascular invasion in esophageal squamous cell carcinoma.基于增强CT的影像组学列线图用于术前预测食管鳞状细胞癌的淋巴管侵犯
Front Oncol. 2023 Jul 3;13:1208756. doi: 10.3389/fonc.2023.1208756. eCollection 2023.

引用本文的文献

1
Computed tomography radiomics combined with clinical parameters for hepatocellular carcinoma differentiation: a machine learning investigation.计算机断层扫描影像组学联合临床参数用于肝细胞癌分化:一项机器学习研究
Pol J Radiol. 2025 Mar 24;90:e140-e150. doi: 10.5114/pjr/200631. eCollection 2025.
2
Application of CT-based radiomics combined with laboratory tests such as AFP and PIVKA-II in preoperative prediction of pathologic grade of hepatocellular carcinoma.基于CT的影像组学联合甲胎蛋白(AFP)和异常凝血酶原(PIVKA-II)等实验室检查在肝细胞癌病理分级术前预测中的应用。
BMC Med Imaging. 2025 Feb 17;25(1):51. doi: 10.1186/s12880-025-01588-2.

本文引用的文献

1
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
2
Multiparametric MRI and Machine Learning Based Radiomic Models for Preoperative Prediction of Multiple Biological Characteristics in Prostate Cancer.基于多参数磁共振成像和机器学习的放射组学模型用于前列腺癌多种生物学特征的术前预测
Front Oncol. 2022 Feb 7;12:839621. doi: 10.3389/fonc.2022.839621. eCollection 2022.
3
Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading.
肝细胞癌分级的增强CT影像组学分析
Front Oncol. 2021 Jun 4;11:660509. doi: 10.3389/fonc.2021.660509. eCollection 2021.
4
Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.基于增强 CT 影像组学构建预测晚期 HCC 患者抗 PD-1 抗体治疗疗效的列线图模型的建立与验证
Front Immunol. 2021 Jan 8;11:613946. doi: 10.3389/fimmu.2020.613946. eCollection 2020.
5
Texture Analysis of Hepatocellular Carcinoma on Magnetic Resonance Imaging: Assessment for Performance in Predicting Histopathologic Grade.磁共振成像对肝细胞癌的纹理分析:预测组织病理学分级的性能评估
J Comput Assist Tomogr. 2020 Nov/Dec;44(6):901-910. doi: 10.1097/RCT.0000000000001087.
6
Radiomics Analysis of Susceptibility Weighted Imaging for Hepatocellular Carcinoma: Exploring the Correlation between Histopathology and Radiomics Features.磁共振扩散加权成像纹理分析在肝癌中的应用:探讨病理组织学与纹理特征的相关性。
Magn Reson Med Sci. 2021 Sep 1;20(3):253-263. doi: 10.2463/mrms.mp.2020-0060. Epub 2020 Aug 12.
7
Role of baseline volumetric functional MRI in predicting histopathologic grade and patients' survival in hepatocellular carcinoma.基线容积功能 MRI 在预测肝细胞癌组织病理学分级和患者生存中的作用。
Eur Radiol. 2020 Jul;30(7):3748-3758. doi: 10.1007/s00330-020-06742-8. Epub 2020 Mar 6.
8
High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.高全身免疫炎症指数是胃食管腺癌患者的不良预后因素。
Ann Surg. 2021 Mar 1;273(3):532-541. doi: 10.1097/SLA.0000000000003370.
9
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas.整合多组学分析揭示肝癌的全面肿瘤异质性和新型免疫表型分类。
Gut. 2019 Nov;68(11):2019-2031. doi: 10.1136/gutjnl-2019-318912. Epub 2019 Jun 21.
10
Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study.肝细胞癌患者预后列线图的开发与外部验证:一项基于人群的研究
Cancer Manag Res. 2019 Apr 10;11:2691-2708. doi: 10.2147/CMAR.S191287. eCollection 2019.